Chronic Pruritus: Current and Emerging Treatment Options.

about

Neuropathic symptoms of the ocular surface: dryness, pain, and itch.Neuro-immune interactions in allergic diseases: novel targets for therapeutics.

P2860

Q40062999-B9F0D090-2783-4618-BCC5-680D26EE3AA9 Q47800446-131E5C22-599E-499F-82A1-62B606C5FC10

P2860

Chronic Pruritus: Current and Emerging Treatment Options.

Item

http://www.wikidata.org/entity/Q39156148

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Chronic Pruritus: Current and Emerging Treatment Options.

@en

Chronic Pruritus: Current and Emerging Treatment Options.

@nl

type

Item

label

Chronic Pruritus: Current and Emerging Treatment Options.

@en

Chronic Pruritus: Current and Emerging Treatment Options.

@nl

prefLabel

Chronic Pruritus: Current and Emerging Treatment Options.

@en

Chronic Pruritus: Current and Emerging Treatment Options.

@nl

P1476

Chronic Pruritus: Current and Emerging Treatment Options

@en

P2093

Manuel P Pereira

http://www.w3.org/2001/XMLSchema#string

P2860

New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?

Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.

Mechanisms of action of cyclosporine.

The role of substance P in inflammatory disease.

The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.

Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia.

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus.

P2888

s40265-017-0746-9

P304

999-1007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0746-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sonja Ständer

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28466423

http://www.w3.org/2001/XMLSchema#string

Chronic Pruritus: Current and Emerging Treatment Options.

about

P2860

P2860

Chronic Pruritus: Current and Emerging Treatment Options.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698